Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 4, 1998, Pages 287-294

  Yuen, Y H ^a   Chang, S ^a   Chong, C K L ^a   Lee, S C ^b   Critchley, J A J H ^a   Chan, J C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; SOTALOL; SULFONYLUREA;

ARTICLE; DRUG COST; DRUG UTILIZATION; HOSPITAL; OUTPATIENT DEPARTMENT; PRESCRIPTION; TEACHING HOSPITAL;

AGED; ANTIHYPERTENSIVE AGENTS; DATA COLLECTION; DRUG COSTS; DRUG UTILIZATION; FEMALE; HONG KONG; HOSPITALS, TEACHING; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 0031721185     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00161.x     Document Type: Article

References (31)

1. DeFronzo RA, Ferrannini E. (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194.
2. Cockram CS, Woo J, Lau E, Chan JCN, Chan AYW, Lau J, et al. (1993) The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Research and Clinical Practice, 21, 67-73.
3. Chan JCN, Cheung JCK, Lau EMC, Woo J, Swaminathan R, Cockram CS. (1996) The Metabolic Syndrome in Hong Kong Chinese - the interrelationships among its components analyzed by structural equation modeling. Diabetes Care, 19, 953-959.
4. Strube G. (1993) Prescribing within a budget. Practitioner, 237, 73-75.
5. Ferguson RI, Salmond CE, Maling TJB. (1995) The Nelson Prescribing Project. A programmed intervention in general practice in New Zealand. Pharmacoeconomics, 7, 555-561.
6. Knorr M, Frielingsdorf J, Graf F, Vetter H, Vetter W. (1987) Prescription patterns and costs of antihypertensive drugs in two outpatient clinics: Zürich (Switzerland) and Münster (FRG), 1975-85. Nephron, 47(Suppl. 1), 120-124.
7. Baksaas I. (1984) Patterns in drug utilization - National and international aspects: antihypertensive drugs. Acta Medica Scandinavica, 683(Suppl.), 59-66.
8. Carter BL, Kriesel HT, Steinkraus L, Knudson R. (1989) Antihypertensive drug-prescribing patterns of internists and family physicians. The Journal of Family Practice, 29, 257-262.
9. Feldman HI, Strom BL. (1991) Utilisation of drugs for diabetes mellitus. Drug Safety, 6, 220-229.
10. Chapman S. (1994) A view using prescribing analyses and cost trends data. Cardiology, 85(Suppl. 1), 46-53.
11. Anon. (1997) Cardiovascular drugs. In: Mehta DK (ed.). British National Formulary, Number 33. London: The Pharmaceutical Press, 60-101.
12. Lau GSN, Chan JCN, Chu PLM, Tse DCK, Critchley JAJH. (1996) Use of anti-diabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Annals of Pharmacotherapy, 30, 232-237.
13. McGavock H. (1988) Some patterns of prescribing by urban general practitioners. British Medical Journal, 296, 900-902.
14. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. (1990) Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet, 335, 827-838.
15. Lithell HOL. (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care, 40, 203-209.
16. Chan JCN, Cockram CS, Critchley JAJH. (1996) Drug-induced disorders of glucose metabolism - mechanisms and management. Drug Safety, 15, 135-157.
17. Christlieb AR. (1990) Treatment selection considerations for the hypertensive diabetic patient. Archives of Internal Medicine, 150, 1167-1174.
18. Robinson MT. (1995) Antihypertensive drugs in the elderly. Australian Pharmacist, 14, 321-326.
19. Pfeffer MA, Braunwald E, Moyé LA, et al. (1992) on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. New England Journal of Medicine, 327, 669-677.
20. Rodby RA, Firth LM, Lewis EJ, The Collaborative Study Group. (1996) An economic analysis of captopril in the treatment of diabetic nephropathy. Diabetes Care, 19, 1051-1061.
21. Anon. (1996) Editorial. Calcium channel blockers: managing uncertainty. Lancet, 328, 487-489.
22. Bühler FR, Hulthén UL, Kiowski W, Bolli P. (1982) Greater antihypertensive efficacy of the calcium channel inhibitor verapamil in older and low renin patients. Clinical Science, 63, S439-S442.
23. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. New England Journal of Medicine, 335, 1107-1114.
24. O'Callaghan PA, McGovern BA. (1996) Evolving role of sotalol in the management of ventricular tachyarrhythmias. American Journal of Cardiology, 78, 54-60.
25. Levy D, Walmsley P, Levenstein M. (1996) Principal results of the Hypertension and Lipid Trial (HALT): a multicentre study of doxazosin in patients with hypertension. American Heart Journal, 131, 966-973.
26. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. (1990) The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine, 150, 1881-1884.
27. Ferguson RP, Wetle T, Dubitzky D, Winsemius D. (1994) Relative importance to elderly patients of effectiveness, adverse effects, convenience and cost of antihypertensive medications. A pilot study. Drugs and Aging, 4, 56-62.
28. Prisant LM, Weir MR, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, et al. (1995) Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. American Heart Journal, 130, 359-366.
29. Gerich JE. (1989) Oral hypoglycemic agents. Mew England Journal of Medicine, 321, 1231-1245.
30. Chan TYK, Chan JCN, Critchley JAJH. (1992) Severe hypoglycaemia in Chinese patients with non-insulin-dependent diabetes treated with insulin or sulphonylureas. Pharmacoepidemiology and Drug Safety, 1, 207-211.
31. Chan JCN, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS. (1993) Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgraduate Medical Journal, 69, 204-210.